Roger P. Smith
No ORCID on file
· 7 papers in corpus
· active 1984-2018
STUDY QUESTION: What is the safe and pharmacodynamically active dose range for PDC31 (prostaglandin F2α receptor inhibitor) in patients with primary dysmenorrhea (PD)? SUMMARY ANSWER: The 1 mg/kg/h dose of PDC31 appears to be safe and poten…
A specially designed pain questionnaire can assist in the diagnosis and management of patients with ‘chronic pelvic pain’. Questionnaires used generally include information about demographics, a medical, sexual and marital history, an asses…
Assessment of cases of chronic pelvic pain presents a challenging problem, and many physicians overlook the association of sleep disorders and depression with such pain. We examined these linkages in our chronic pelvic pain clinic, using a …